Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 31;15(2):403.
doi: 10.3390/v15020403.

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana

Affiliations

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana

Kenanao Kotokwe et al. Viruses. .

Abstract

It remains unknown whether the C-C motif chemokine receptor type 5 (CCR5) coreceptor is still the predominant coreceptor used by Human Immunodeficiency Virus-1 (HIV-1) in Botswana, where the HIV-1 subtype C predominates. We sought to determine HIV-1C tropism in Botswana using genotypic tools, taking into account the effect of antiretroviral treatment (ART) and virologic suppression. HIV-1 gp120 V3 loop sequences from 5602 participants were analyzed for viral tropism using three coreceptor use predicting algorithms/tools: Geno2pheno, HIV-1C Web Position-Specific Score Matrices (WebPSSM) and the 11/25 charge rule. We then compared the demographic and clinical characteristics of people living with HIV (PLWH) harboring R5- versus X4-tropic viruses using χ2 and Wilcoxon rank sum tests for categorical and continuous data analysis, respectively. The three tools congruently predicted 64% of viruses as either R5-tropic or X4-tropic. Geno2pheno and the 11/25 charge rule had the highest concordance at 89%. We observed a significant difference in ART status between participants harboring X4- versus R5-tropic viruses. X4-tropic viruses were more frequent among PLWH receiving ART (χ2 test, p = 0.03). CCR5 is the predominant coreceptor used by HIV-1C strains circulating in Botswana, underlining the strong potential for CCR5 inhibitor use, even in PLWH with drug resistance. We suggest that the tools for coreceptor prediction should be used in combination.

Trial registration: ClinicalTrials.gov NCT01965470.

Keywords: CCR5; CXCR4; HIV-1C tropism; R5-tropic viruses; X4-tropic viruses.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that they have no competing interests related to this study.

Similar articles

Cited by

References

    1. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–666. doi: 10.1038/381661a0. - DOI - PubMed
    1. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667–673. doi: 10.1038/381667a0. - DOI - PubMed
    1. Sollerkvist L.P., Gaseitsiwe S., Mine M., Sebetso G., Mphoyakgosi T., Diphoko T., Essex M., Ehrnst A. Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in patients failing antiretroviral treatment compared with treatment-naive patients in Botswana. AIDS Res. Hum. Retrovir. 2014;30:436–445. doi: 10.1089/aid.2013.0203. - DOI - PubMed
    1. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997;185:621–628. doi: 10.1084/jem.185.4.621. - DOI - PMC - PubMed
    1. Casper C., Naver L., Clevestig P., Belfrage E., Leitner T., Albert J., Lindgren S., Ottenblad C., Bohlin A.B., Fenyo E.M., et al. Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes. AIDS Res. Hum. Retrovir. 2002;18:343–352. doi: 10.1089/088922202753519124. - DOI - PubMed

Publication types

Substances

Associated data